Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 29, 2015
Patent Application Number
14403787
Date Filed
June 7, 2013
Patent Primary Examiner
Patent abstract
The invention provides heterocyclic guanidine compounds that inhibit F1F0-ATPase, and methods of using heterocyclic guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.